ABSTRACT Ia.W39 is a private specificity of the I-Ab subregion of the H-2 complex. It is selectively expressed on a subset of B lymphocytes that is absent in newborn normal and adult mutant mice carrying the xid gene. Immunoprecipitation and one-dimensional NaDodSO4/polyacrylamide gel electrophoresis showed that the molecule bearing Ia.W39 consists of two noncovalently linked glycoproteins of apparent Mr 33,000 and 28,000. Anti-Ia.W39 serum did not preclear the Jab molecule; however, the conventional allo-anti-l-Ab serum cleared Ia.W39 completely. In view of the identical two-dimensional gel pattern generated by the Ia.W39 and the conventional lab immunoprecipitates, we believe that all Ia molecules bear the conventional specificities and only a subset would in addition express Ia.W39. Ia.W39 is probably not a carbohydrate antigen, because the antibiotic tunicamycin had no influence on its expression. It may be a conformational determinant on the Aa and A13 complex induced by the association of an unknown molecule with these chains.
the molecule bearing Ia.W39 consists of two noncovalently linked glycoproteins of apparent Mr 33,000 and 28,000. Anti-Ia.W39 serum did not preclear the Jab molecule; however, the conventional allo-anti-l-Ab serum cleared Ia.W39 completely. In view of the identical two-dimensional gel pattern generated by the Ia.W39 and the conventional lab immunoprecipitates, we believe that all Ia molecules bear the conventional specificities and only a subset would in addition express Ia.W39. Ia.W39 is probably not a carbohydrate antigen, because the antibiotic tunicamycin had no influence on its expression. It may be a conformational determinant on the Aa and A13 complex induced by the association of an unknown molecule with these chains.
Since the discovery that immune response (Ir) genes map within the major histocompatibility complex (1, 2) , the I region has been a focus ofattention for immunologists. Ia specificities have been associated with the I region ofthe histocompatibility complex in many mammalian species (3) (4) (5) (6) (7) (8) (9) (10) . The functional role of the Ia antigens is still not fully understood. Many speculations have been made about their role as cell interaction molecules (11) (12) (13) or as products of the Ir genes themselves (14) . The Ia molecule, in every species studied so far, is composed of two noncovalently linked glycoproteins that are products of loci in the I region, namely, an a chain of Mr =33,000 and a f chain of Mr ==28,000 (for review, see ref. 15) . A third polypeptide, the Ia-associated invariant chain (Ii) is found in murine (16) and human (17) Ia immunoprecipitates. In the mouse, Ia antigens are expressed on more than 95% of B cells (4), 30-50% of macrophages (18, 19) and dendritic cells (20) , and on a low, serologically and biochemically undetectable number ofhelper (21) and suppressor (7) T cells. Recently, a new Ia specificity, Ia.W39, has been defined that is private for I-Ab and has a unique tissue distribution pattern (22) . It is a B-cell-differentiation antigen whose expression is controlled by a gene on the X chromosome (xid) (23) like other B-cell-differentiation markers-e.g., Lyb3 (24) , Lyb5 (25) , and Lyb7 (26) . It is expressed on =50% of mature splenic B cells, which are absent in mice carrying the defective xid gene. It is also expressed on a subset of macrophages, and it is essential for optimal presentation of beef insulin, an antigen that is under Ir control mapping in the I-Ab region (27) Anti-Ia.W39 was prepared by immunizing (CBA/N X B6)Fl male mice with B6 spleen cells as described (22) .
Microcytotoxicity Assay. Cell suspensions were treated with low ionic strength buffer (28) to lyse the dead cells, which resulted in 95-98% live cells. Cells at 5 x 105/10 ,ul were incubated for 20 min on ice with 25 ,ul ofantiserum or normal mouse serum (NMS) at various dilutions in V-bottom microtiter plates (Linbro, Titertek). Then, 35 ,ul of preabsorbed rabbit C at a dilution of 1:6 (final dilution 1:12) was added, and the plate was incubated at 37°C on a rocker for 0.5 hr. The C reaction was stopped by addition of 80 ,ul of cold medium, and the viability counts were performed with phase-contrast microscopy. The percent specific killing was calculated as (% dead cells with antiserum -% dead cells with NMS) x 100/(100 -% dead cells with NMS).
Metabolic Labeling Procedure with [3S]Methionine. Cells (2 X 107) were pelleted and suspended in 15 ml of methioninefree RPMI 1640/10% dialyzed fetal calf serum/0.5 mCi of
[3S]methionine (800 Ci/mmol, 1 Ci = 3.7 X 10"°becquerels; New England Nuclear). The cells were incubated at 37°C in 5% C02/95% air for [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] hr, pelleted, and lysed by spinning in a Vortex and addition of 2 ml of 0.5% Triton X-100/1 mM a-toluenesulphonyl fluoride/0.25 mM dithiothreitol/10 mM Tris base, pH 7.4. The mixture was incubated at 4°C for 0.5 hr and then centrifuged at 50,000 rpm (g average = 150,000). The resulting supernatant was used for the immunoprecipitation studies.
Tunicamycin Treatment. Cells (5 x 107/ml) were suspended in methionine-free RPMI 1640/10% dialyzed fetal calf serum and incubated for 1 hr at 37°C with tunicamycin (2-10 jig/ml) (a gift of Hide Ploegh, Harvard University). This antibiotic specifically blocks N-linked glycosylation of asparagine residues of glycoproteins by inhibiting the synthesis ofthe lipid-linked precursor oligosaccharide (29, 30) 
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Immunology: Huber et alP tunicamycin was within the range seen in control cultures-i.e., 10-15%) . The cells were then labeled with [3S]methionine as described above.
Lectin Affinity Chromatography. Sepharose-coupled Lens culinaris agglutinin (lentil) was obtained from Vector Laboratories (Burlingame, CA). Samples ofthe radiolabeled cell lysates were loaded onto the lentil affinity column (0.2 ml) at the maximum flow rate. The column was preequilibrated with 0.2% Triton X-100/0. 1 mM MgCl2/0. 14M NaCl/0.25 mM dithiothreitoV10 mM Tris base, pH 7.8 (lectin buffer) and washed with 5-10 column volumes of lectin buffer after application of the sample. a-Methyl mannoside (Sigma) at 3% (wt/vol) in 1 ml of lectin buffer was run into the column, which was then turned off and allowed to stand for 30 min. The specifically bound material was eluted by using the same sugar solution. All procedures were performed at 4TC.
Immunoprecipitation with Formalin-Fixed Staphylococcus aureus and NaDodSO4Polyacrylamide Gel Electrophoresis.
These procedures were exactly as described by Kessler (31) . Samples were run on 10% NaDodSOjpolyacrylamide gels, except for the tunicamycin experiment, where a discontinuous gel was used as described by Laemmli (32) . This gel contained a 7-15% linear acrylamide gradient. Two-Dimensional Polyacrylamide Gel Electrophoresis. Samples were prepared and subjected to electrophoresis according to published procedures (33) . Briefly, immunoprecipitated proteins were separated on nonequilibrium pH gradient gels in the first dimension and then according to size on 10% NaDodSOJpolyacrylamide gels in the second dimension. cells from B6 mice at various ages. In contrast, we found that Ia. W39 could be detected by cytotoxicity on a significant number of spleen cells in 3-week-old mice only ( Fig. 2A) .
In parallel experiments, we carried out immunoprecipitations on B6 spleen cells during ontogeny. The conventional Ia molecule, immunoprecipitated from the various spleen cell lysates after 24 hr ofmetabolic labeling with [3S]methionine and the time course of the appearance of the molecule carrying the Ia.W39 specificity are shown in Fig. 2 (Fig. 3, lanes 1 and 2) . However, when the same experiment was performed on cells labeled for 5 hr, anti-Ia.W39 serum precipitated ,B chain only, although anti-I-Ab serum could still precipitate both a and ,B chains (Fig. 3, lanes 3 and 4) 7) and anti-Ia.W39 (lanes 8-14) sera. The spleen cells were labeled with [35Slmethionine for 24 hr. Mice of the various age groups were pooled. Lanes: 1 and 8, neonates (<24 hr); 2 and 9, day 5; 3 and 10, day 8; 4 and 11, day 9; 5 and 12, day 11; 6 and 13, day 13; 7 and 14, day 19. Indicated bands are as described in the legend to Fig. 1. I-Ab and anti-Ia. W39 sera still immunoprecipitate proteins after treatment with this antibiotic (Fig. 4) (Fig. 6) . Surprisingly, both the a immunorrecipitates from untreated cell extracts using anti-Ia.W39 or anti-I-A serum, respectively; 3 and 4, immunoprecipitates from ex-'tracts of cells treated with tunicamycin at 2 jig/ml; 5 and 6, immunoprecipitates of cells treated with tunicamycin at 5 pg/ml. Immunoprecipitates using anti-Ia.W39 serum are in lanes 3 and 5, and immunoprecipitates using anti-I-Ab serum are in lanes 4 and 6. These precipitates were run on a discontinuous 7-15% NaDodSO4, linear acrylamide gradient, which splits the normal two-band Ia pattern into three bands. The middle band corresponds to the Ii chain. membranes. The same time course ofappearance seems to take place in macrophages; we found that macrophages of neonatal (up to 10-day-old) B6 mice were able to present trinitrophenylated ovalbumin, but not beef insulin, to immune T cells. The expression of conventional Ia on antigen-presenting cells is sufficient for the former antigen, although Ia.W39 is essential for the latter (27) .
A late addition of a new antigenic marker on a normal Ia molecule could be explained easily, ifit would be a carbohydrate specificity. To test this, we used the antibiotic tunicamycin, which inhibits N-linked glycosylation. However, previous treatment with this drug did not interfere with the specific immunoprecipitation by either anti-Ia. W39 or anti-Iab serum. The constant shift in apparent molecular weight after tunicamycin treatment at various doses (2-5 ug) is proof that N-linked glycosylation was inhibited completely. These studies do not rule out the possibility of 0-linked glycosylation; however, this is rarely found on membrane proteins.
By using conventional alloantisera, five specificities (Ia.3, .8, .9, .15, and .20) have been described, all coded for within the I-Ab subregion. Apparently, they all exist on the same molecule, as they are coprecipitable (37) . The fact that only anti-Iab serum could preclear Ia.W39 but not vice versa can be interpreted in a number ofways. The most likely explanation is that all molecules bear the conventional specificities, but a subset expresses the Ia.W39 antigen. The allo-anti-I-Ab serum could therefore also contain antibodies directed against Ia.W39. Consistent with this idea is the finding that anti-I-Ab serum can block T-cell proliferation to beef insulin to the same extent as anti-Ia.W39 serum, although only the Ia.W39 specificity is associated with this Ir gene (27) . Another possible explanation involved a posttranslational modification of Ia that would take place in mature B cells, leading to the appearance ofthe Ia.W39 specificity. The tunicamycin experiment, however, suggests that this posttranslational alteration is not an N-linked glycosylation.
The data obtained in the two-dimensional gel analysis are compatible with two models. (i) The molecules bearing Ia. W39 or conventional specificities (or both) are encoded by the same gene(s) and have identical chains, but are folded differently due to interaction with other membrane determinants that are controlled by xid-e.g., Lyb3, 5, or 7. (ii) The two molecules differ at uncharged amino acids and, therefore, are products of separate, maybe duplicated, genes. This would imply an extensive polymorphism within the I-A" molecule species. Another possibility should also be considered; namely, that Ia.W39 is associated with a different molecule (e.f., glycolipid or small protein) that binds noncovalently to I-A 
